Global Immunotherapy Market Insights and Forecast to 2028

Global Immunotherapy Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Immunotherapy Product Introduction
1.2 Market by Type
1.2.1 Global Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Non-Specific Immunotherapy
1.3 Market by Application
1.3.1 Global Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Inflammation
1.3.4 Central Nervous System
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Immunotherapy Sales Estimates and Forecasts 2017-2028
2.2 Global Immunotherapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Immunotherapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Immunotherapy Sales by Region
2.4.1 Global Immunotherapy Sales by Region (2017-2022)
2.4.2 Global Sales Immunotherapy by Region (2023-2028)
2.5 Global Immunotherapy Revenue by Region
2.5.1 Global Immunotherapy Revenue by Region (2017-2022)
2.5.2 Global Immunotherapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Immunotherapy Sales by Manufacturers
3.1.1 Global Top Immunotherapy Manufacturers by Sales (2017-2022)
3.1.2 Global Immunotherapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunotherapy in 2021
3.2 Global Immunotherapy Revenue by Manufacturers
3.2.1 Global Immunotherapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Immunotherapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2021
3.3 Global Immunotherapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Immunotherapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immunotherapy Sales by Type
4.1.1 Global Immunotherapy Historical Sales by Type (2017-2022)
4.1.2 Global Immunotherapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Immunotherapy Sales Market Share by Type (2017-2028)
4.2 Global Immunotherapy Revenue by Type
4.2.1 Global Immunotherapy Historical Revenue by Type (2017-2022)
4.2.2 Global Immunotherapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Immunotherapy Revenue Market Share by Type (2017-2028)
4.3 Global Immunotherapy Price by Type
4.3.1 Global Immunotherapy Price by Type (2017-2022)
4.3.2 Global Immunotherapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Immunotherapy Sales by Application
5.1.1 Global Immunotherapy Historical Sales by Application (2017-2022)
5.1.2 Global Immunotherapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Immunotherapy Sales Market Share by Application (2017-2028)
5.2 Global Immunotherapy Revenue by Application
5.2.1 Global Immunotherapy Historical Revenue by Application (2017-2022)
5.2.2 Global Immunotherapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Immunotherapy Revenue Market Share by Application (2017-2028)
5.3 Global Immunotherapy Price by Application
5.3.1 Global Immunotherapy Price by Application (2017-2022)
5.3.2 Global Immunotherapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Immunotherapy Market Size by Type
6.1.1 North America Immunotherapy Sales by Type (2017-2028)
6.1.2 North America Immunotherapy Revenue by Type (2017-2028)
6.2 North America Immunotherapy Market Size by Application
6.2.1 North America Immunotherapy Sales by Application (2017-2028)
6.2.2 North America Immunotherapy Revenue by Application (2017-2028)
6.3 North America Immunotherapy Market Size by Country
6.3.1 North America Immunotherapy Sales by Country (2017-2028)
6.3.2 North America Immunotherapy Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Immunotherapy Market Size by Type
7.1.1 Europe Immunotherapy Sales by Type (2017-2028)
7.1.2 Europe Immunotherapy Revenue by Type (2017-2028)
7.2 Europe Immunotherapy Market Size by Application
7.2.1 Europe Immunotherapy Sales by Application (2017-2028)
7.2.2 Europe Immunotherapy Revenue by Application (2017-2028)
7.3 Europe Immunotherapy Market Size by Country
7.3.1 Europe Immunotherapy Sales by Country (2017-2028)
7.3.2 Europe Immunotherapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Immunotherapy Market Size by Type
8.1.1 Asia Pacific Immunotherapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Immunotherapy Revenue by Type (2017-2028)
8.2 Asia Pacific Immunotherapy Market Size by Application
8.2.1 Asia Pacific Immunotherapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Immunotherapy Revenue by Application (2017-2028)
8.3 Asia Pacific Immunotherapy Market Size by Region
8.3.1 Asia Pacific Immunotherapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Immunotherapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Immunotherapy Market Size by Type
9.1.1 Latin America Immunotherapy Sales by Type (2017-2028)
9.1.2 Latin America Immunotherapy Revenue by Type (2017-2028)
9.2 Latin America Immunotherapy Market Size by Application
9.2.1 Latin America Immunotherapy Sales by Application (2017-2028)
9.2.2 Latin America Immunotherapy Revenue by Application (2017-2028)
9.3 Latin America Immunotherapy Market Size by Country
9.3.1 Latin America Immunotherapy Sales by Country (2017-2028)
9.3.2 Latin America Immunotherapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immunotherapy Market Size by Type
10.1.1 Middle East and Africa Immunotherapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Immunotherapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Immunotherapy Market Size by Application
10.2.1 Middle East and Africa Immunotherapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Immunotherapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Immunotherapy Market Size by Country
10.3.1 Middle East and Africa Immunotherapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Immunotherapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbvie
11.1.1 Abbvie Corporation Information
11.1.2 Abbvie Overview
11.1.3 Abbvie Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbvie Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbvie Recent Developments
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Corporation Information
11.2.2 Amgen, Inc. Overview
11.2.3 Amgen, Inc. Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen, Inc. Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen, Inc. Recent Developments
11.3 Biogen
11.3.1 Biogen Corporation Information
11.3.2 Biogen Overview
11.3.3 Biogen Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biogen Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bristol-Myers Squibb Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Celgene
11.5.1 Celgene Corporation Information
11.5.2 Celgene Overview
11.5.3 Celgene Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Celgene Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Celgene Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Overview
11.9.3 Pfizer Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pfizer Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pfizer Recent Developments
11.10 Roche
11.10.1 Roche Corporation Information
11.10.2 Roche Overview
11.10.3 Roche Immunotherapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Roche Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immunotherapy Industry Chain Analysis
12.2 Immunotherapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunotherapy Production Mode & Process
12.4 Immunotherapy Sales and Marketing
12.4.1 Immunotherapy Sales Channels
12.4.2 Immunotherapy Distributors
12.5 Immunotherapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Immunotherapy Industry Trends
13.2 Immunotherapy Market Drivers
13.3 Immunotherapy Market Challenges
13.4 Immunotherapy Market Restraints
14 Key Findings in The Global Immunotherapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Therapeutic Vaccines
Table 4. Major Manufacturers of Checkpoint Inhibitors
Table 5. Major Manufacturers of Non-Specific Immunotherapy
Table 6. Global Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Immunotherapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 9. Global Immunotherapy Sales Market Share by Region (2017-2022)
Table 10. Global Immunotherapy Sales by Region (2023-2028) & (K Units)
Table 11. Global Immunotherapy Sales Market Share by Region (2023-2028)
Table 12. Global Immunotherapy Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Immunotherapy Revenue Market Share by Region (2017-2022)
Table 14. Global Immunotherapy Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Immunotherapy Revenue Market Share by Region (2023-2028)
Table 16. Global Immunotherapy Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Immunotherapy Sales Share by Manufacturers (2017-2022)
Table 18. Global Immunotherapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Immunotherapy Revenue Share by Manufacturers (2017-2022)
Table 20. Immunotherapy Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2021)
Table 23. Immunotherapy Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Immunotherapy Product Offered
Table 25. Date of Manufacturers Enter into Immunotherapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 28. Global Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 29. Global Immunotherapy Sales Share by Type (2017-2022)
Table 30. Global Immunotherapy Sales Share by Type (2023-2028)
Table 31. Global Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Immunotherapy Revenue Share by Type (2017-2022)
Table 34. Global Immunotherapy Revenue Share by Type (2023-2028)
Table 35. Immunotherapy Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Immunotherapy Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 38. Global Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 39. Global Immunotherapy Sales Share by Application (2017-2022)
Table 40. Global Immunotherapy Sales Share by Application (2023-2028)
Table 41. Global Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Immunotherapy Revenue Share by Application (2017-2022)
Table 44. Global Immunotherapy Revenue Share by Application (2023-2028)
Table 45. Immunotherapy Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Immunotherapy Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 48. North America Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 49. North America Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 52. North America Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 53. North America Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 56. North America Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 57. North America Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 60. Europe Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 61. Europe Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 64. Europe Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 65. Europe Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 68. Europe Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 69. Europe Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Immunotherapy Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Immunotherapy Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Immunotherapy Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Immunotherapy Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Immunotherapy Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Immunotherapy Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Immunotherapy Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 107. Abbvie Corporation Information
Table 108. Abbvie Description and Major Businesses
Table 109. Abbvie Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Abbvie Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Abbvie Recent Developments
Table 112. Amgen, Inc. Corporation Information
Table 113. Amgen, Inc. Description and Major Businesses
Table 114. Amgen, Inc. Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Amgen, Inc. Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen, Inc. Recent Developments
Table 117. Biogen Corporation Information
Table 118. Biogen Description and Major Businesses
Table 119. Biogen Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Biogen Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biogen Recent Developments
Table 122. Bristol-Myers Squibb Corporation Information
Table 123. Bristol-Myers Squibb Description and Major Businesses
Table 124. Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Bristol-Myers Squibb Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bristol-Myers Squibb Recent Developments
Table 127. Celgene Corporation Information
Table 128. Celgene Description and Major Businesses
Table 129. Celgene Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Celgene Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Celgene Recent Developments
Table 132. Johnson & Johnson Corporation Information
Table 133. Johnson & Johnson Description and Major Businesses
Table 134. Johnson & Johnson Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Johnson & Johnson Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Johnson & Johnson Recent Developments
Table 137. Merck Corporation Information
Table 138. Merck Description and Major Businesses
Table 139. Merck Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Merck Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck Recent Developments
Table 142. Novartis Corporation Information
Table 143. Novartis Description and Major Businesses
Table 144. Novartis Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Novartis Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Novartis Recent Developments
Table 147. Pfizer Corporation Information
Table 148. Pfizer Description and Major Businesses
Table 149. Pfizer Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Pfizer Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Pfizer Recent Developments
Table 152. Roche Corporation Information
Table 153. Roche Description and Major Businesses
Table 154. Roche Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Roche Immunotherapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Roche Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Immunotherapy Distributors List
Table 160. Immunotherapy Customers List
Table 161. Immunotherapy Market Trends
Table 162. Immunotherapy Market Drivers
Table 163. Immunotherapy Market Challenges
Table 164. Immunotherapy Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunotherapy Product Picture
Figure 3. Global Immunotherapy Market Share by Type in 2021 & 2028
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Therapeutic Vaccines Product Picture
Figure 5. Checkpoint Inhibitors Product Picture
Figure 6. Non-Specific Immunotherapy Product Picture
Figure 7. Global Immunotherapy Market Share by Application in 2021 & 2028
Figure 8. Oncology
Figure 9. Inflammation
Figure 10. Central Nervous System
Figure 11. Others
Figure 12. Immunotherapy Report Years Considered
Figure 13. Global Immunotherapy Sales 2017-2028 (K Units)
Figure 14. Global Immunotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Immunotherapy Revenue 2017-2028 (US$ Million)
Figure 16. Global Immunotherapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Immunotherapy Sales Market Share by Region (2017-2022)
Figure 18. Global Immunotherapy Sales Market Share by Region (2023-2028)
Figure 19. North America Immunotherapy Sales YoY (2017-2028) & (K Units)
Figure 20. North America Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Immunotherapy Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Immunotherapy Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Immunotherapy Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Immunotherapy Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Immunotherapy Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Immunotherapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Immunotherapy in the World: Market Share by Immunotherapy Revenue in 2021
Figure 31. Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Immunotherapy Sales Market Share by Type (2017-2028)
Figure 33. Global Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 34. Global Immunotherapy Sales Market Share by Application (2017-2028)
Figure 35. Global Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 36. North America Immunotherapy Sales Market Share by Type (2017-2028)
Figure 37. North America Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 38. North America Immunotherapy Sales Market Share by Application (2017-2028)
Figure 39. North America Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 40. North America Immunotherapy Sales Share by Country (2017-2028)
Figure 41. North America Immunotherapy Revenue Share by Country (2017-2028)
Figure 42. U.S. Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Immunotherapy Sales Market Share by Type (2017-2028)
Figure 45. Europe Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 46. Europe Immunotherapy Sales Market Share by Application (2017-2028)
Figure 47. Europe Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 48. Europe Immunotherapy Sales Share by Country (2017-2028)
Figure 49. Europe Immunotherapy Revenue Share by Country (2017-2028)
Figure 50. Germany Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 51. France Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Immunotherapy Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Immunotherapy Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Immunotherapy Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Immunotherapy Revenue Share by Region (2017-2028)
Figure 61. China Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 64. India Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Immunotherapy Sales Market Share by Type (2017-2028)
Figure 72. Latin America Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Immunotherapy Sales Market Share by Application (2017-2028)
Figure 74. Latin America Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Immunotherapy Sales Share by Country (2017-2028)
Figure 76. Latin America Immunotherapy Revenue Share by Country (2017-2028)
Figure 77. Mexico Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Immunotherapy Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Immunotherapy Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Immunotherapy Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Immunotherapy Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Immunotherapy Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Immunotherapy Revenue Share by Country (2017-2028)
Figure 86. Turkey Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Immunotherapy Revenue (2017-2028) & (US$ Million)
Figure 89. Immunotherapy Value Chain
Figure 90. Immunotherapy Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs